Activation of ribonucleotide reductase regulatory subunit M2 promotes the progression of ATRT

被引:0
|
作者
Giang, Le H. [1 ,2 ,3 ]
Wong, Taitong [4 ]
Chang, Chechang [1 ,3 ]
机构
[1] TMU, PhD Program Translat Med, Taipei, Taiwan
[2] HPMU, Dept Med Biol & Genet, Hai Phong, Vietnam
[3] TMU, Coll Med Sci & Technol, Taipei, Taiwan
[4] TMU, Grad Inst Clin Med, Taipei, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-1230
引用
收藏
页码:281 / 281
页数:1
相关论文
共 50 条
  • [21] Ribonucleotide reductase subunit M2 plays important role in cisplatin resistance of cancer cells
    Rahman, Mohammad Aminur
    Amin, A. R. M. R.
    Peng, Xianghong
    Zhang, Jun
    Chen, Zhuo G.
    Shin, Dong M.
    CANCER RESEARCH, 2014, 74 (19)
  • [22] EFFECT OF GALLIUM ON THE TYROSYL RADICAL OF THE IRON-DEPENDENT M2 SUBUNIT OF RIBONUCLEOTIDE REDUCTASE
    NARASIMHAN, J
    ANTHOLINE, WE
    CHITAMBAR, CR
    BIOCHEMICAL PHARMACOLOGY, 1992, 44 (12) : 2403 - 2408
  • [23] Serum Ribonucleotide Reductase Subunit M2 in Patients with Chronic Liver Diseases and Hepatocellular Carcinoma
    Jin, Xuehang
    Yu, Wei
    Wang, Ange
    Qiu, Yunqing
    LABORATORY MEDICINE, 2023, 54 (06) : 626 - 632
  • [24] CREB1 directly activates the transcription of ribonucleotide reductase small subunit M2 and promotes the aggressiveness of human colorectal cancer
    Fang, Zejun
    Lin, Aifen
    Chen, Jiaoe
    Zhang, Xiaomin
    Liu, Hong
    Li, Hongzhang
    Hu, Yanyan
    Zhang, Xia
    Zhang, Jiangang
    Qiu, Lanlan
    Mei, Lingming
    Shao, Jimin
    Chen, Xiang
    ONCOTARGET, 2016, 7 (47) : 78055 - 78068
  • [25] Knockdown of ribonucleotide reductase regulatory subunit M2 increases the drug sensitivity of chronic myeloid leukemia to imatinib-based therapy
    Liu, Chunshui
    Li, Yuying
    Hu, Ruiping
    Han, Wei
    Gao, Sujun
    ONCOLOGY REPORTS, 2019, 42 (02) : 571 - 580
  • [26] Prognostic and predictive value of ribonucleotide reductase subunit family M1/M2 in urothelial carcinoma
    Guo, J.
    Xie, W.
    Wang, Q.
    Huang, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S593 - S594
  • [27] Ribonucleotide reductase subunit M2 as a novel target for clear-cell renal cell carcinoma
    Zou, Yun
    Zhou, Juan
    Xu, Bin
    Li, Wenzhi
    Wang, Zhong
    ONCOTARGETS AND THERAPY, 2019, 12 : 3267 - 3275
  • [28] Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer
    Morikawa, Teppei
    Maeda, Daichi
    Kume, Haruki
    Homma, Yukio
    Fukayama, Masashi
    HISTOPATHOLOGY, 2010, 57 (06) : 885 - 892
  • [29] Ribonucleotide Reductase Subunit M2 Can Be New Molecular Target and Prognostic Biomarker of Hepatocellular Carcinoma
    Kim, Hee Yeon
    Kim, Chang Wook
    GUT AND LIVER, 2014, 8 (06) : 580 - 581
  • [30] Increased Expression of Ribonucleotide Reductase Subunit M2 in Adrenal Cortical Carcinoma: Possible Mechanism of Chemoresistance
    Lin, J.
    Thomas, D. G.
    Giordano, T. J.
    LABORATORY INVESTIGATION, 2010, 90 : 130A - 130A